Phosphodiesterase 4 (PDE4) inhibitors can effectively treat inflammation in various tissues/organs caused by conditions such as psoriasis, chronic obstructive pulmonary disease (COPD), asthma, and Alzheimer’s disease [10–12]. This evidence concerns the gene PDE4A and chronic obstructive pulmonary disease.